Understanding celiac disease monitoring patterns and outcomes after diagnosis: A multinational, retrospective chart review study

BACKGROUND Long-term outcomes and monitoring patterns in real-world practice are largely unknown among patients with celiac disease. AIM To understand patterns of follow-up and management of patients with celiac disease, and to characterize symptoms and villous atrophy after diagnosis. METHODS A retrospective chart review study was performed using medical chart data of patients diagnosed with celiac disease. Three gastroenterology referral centers, with substantial expertise in celiac disease, participated in the United Kingdom, United States, and Norway. Demographic and clinical data were collected from medical charts. Descriptive analyses were conducted on patients with biopsy-confirmed celiac disease, diagnosed between 2008 and 2012, with at least one follow-up visit before December 31, 2017. Patient demographic and clinical characteristics, biopsy/serology tests and results, symptoms, and comorbidities were captured at diagnosis and for each clinic visit occurring within the study period (i.e., before the study end date of December 31, 2017). RESULTS A total of 300 patients were included in this study [72% female; mean age at diagnosis: 38.9 years, standard deviation (SD) 17.2]. Patients were followed-up for a mean of 29.9 mo (SD 22.1) and there were, on average, three follow-up visits per patient during the study period. Over two-thirds (68.4%) of patients were recorded as having ongoing gastrointestinal symptoms and 11.0% had ongoing symptoms and enteropathy during follow-up. Approximately 80% of patients were referred to a dietician at least once during the follow-up period. Half (50.0%) of the patients underwent at least one follow-up duodenal biopsy and 36.6% had continued villous atrophy. Patterns of monitoring varied between sites. Biopsies were conducted more frequently in Norway and patients in the United States had a longer follow-up duration. CONCLUSION This real-world study demonstrates variable follow-up of patients with celiac disease despite most patients continuing to have abnormal histology and symptoms after diagnosis.

[1]  D. Sanders,et al.  European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders , 2019, United European gastroenterology journal.

[2]  L. Bolondi,et al.  Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten‐free diet: beyond traditional metabolic factors , 2018, Alimentary pharmacology & therapeutics.

[3]  M. Mearin,et al.  Histopathological evaluation of duodenal biopsy in the PreventCD project. An observational interobserver agreement study , 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[4]  K. Kaukinen,et al.  Performing routine follow‐up biopsy 1 year after diagnosis does not affect long‐term outcomes in coeliac disease , 2017, Alimentary pharmacology & therapeutics.

[5]  D. Schuppan,et al.  Self-reported dietary adherence, disease-specific symptoms, and quality of life are associated with healthcare provider follow-up in celiac disease , 2017, BMC Gastroenterology.

[6]  D. Sanders,et al.  Long-term care for patients with coeliac disease in the UK: a review of the literature and future directions. , 2016, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[7]  M. Ráki,et al.  Long-term mucosal recovery and healing in celiac disease is the rule – not the exception , 2016, Scandinavian journal of gastroenterology.

[8]  P. Gibson,et al.  Adherence to the gluten‐free diet can achieve the therapeutic goals in almost all patients with coeliac disease: A 5‐year longitudinal study from diagnosis , 2016, Journal of gastroenterology and hepatology.

[9]  I. Comino,et al.  Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing , 2015, Gut.

[10]  D. Sanders,et al.  Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology , 2014, Gut.

[11]  A. Rubio‐Tapia,et al.  ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease , 2013, The American Journal of Gastroenterology.

[12]  H. Heini,et al.  Persistent Duodenal Intraepithelial Lymphocytosis Despite a Long-Term Strict Gluten-Free Diet in Celiac Disease , 2012, The American Journal of Gastroenterology.

[13]  P. Green,et al.  Epidemiology and clinical presentations of celiac disease , 2012, Seminars in Immunopathology.

[14]  G. Rubin,et al.  Systematic review: adherence to a gluten‐free diet in adult patients with coeliac disease , 2009, Alimentary pharmacology & therapeutics.

[15]  M. Mazzilli,et al.  HLA-DQ and Susceptibility to Celiac Disease: Evidence for Gender Differences and Parent-of-Origin Effects , 2008, The American Journal of Gastroenterology.

[16]  M. Rashid,et al.  Long-term follow-up of individuals with celiac disease: an evaluation of current practice guidelines. , 2007, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.